Aug. 18 at 1:54 AM
$ICU
Shucks, If ONLY Brad had been smart enough to jump in
$ICU below
$1 after its reverse split. He could've made huge money! instead of a virtual fool of himself.
# # #
Dendreon (DNDN) – Biotech
Reverse Split: Did an early reverse split to stay compliant when shares were under
$1 in early 2000s.
FDA Approval: In 2010, FDA approved Provenge (immunotherapy for prostate cancer).
Stock Surge: Shares spiked over 400% in weeks, from ~
$7 to ~
$40.
# #
DexCom (DXCM) – Medical Device
Reverse Split: 1-for-3 reverse split in 2005 before IPO.
FDA Approval: Received FDA approval in 2006 for its continuous glucose monitoring system (CGM).
Stock Surge: Stock went from small-cap to over
$40B market cap today.
# #
Exact Sciences (EXAS) – Diagnostics (non-drug)
Reverse Split: Did a 1-for-10 reverse split in 2009, when stock was under
$1.
Received FDA approval for Cologuard (at-home colon cancer screening test) in 2014.
Stock Surged to
$100+ at its peak, making it a diagnostic giant.
